Read More 1 minute read Analyst Ratings News Price Target JP Morgan Maintains Overweight on Masonite International, Lowers Price Target to $93 By Benzinga Newsdesk July 15, 9:26 AM JP Morgan analyst Michael Rehaut maintains Masonite International (NYSE:DOOR) with a Overweight and lowers the price target from $110 to $93. DOOR
Read More 1 minute read Analyst Ratings News Price Target JMP Securities Maintains Market Outperform on OppFi, Lowers Price Target to $5 By Benzinga Newsdesk July 15, 9:25 AM JMP Securities analyst David Scharf maintains OppFi (NYSE:OPFI) with a Market Outperform and lowers the price target from $6 to $5. OPFI
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Amgen, Raises Price Target to $253 By Benzinga Newsdesk July 15, 9:23 AM Morgan Stanley analyst Matthew Harrison maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $239 to $253. AMGN
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on American Homes 4 Rent, Lowers Price Target to $37.5 By Benzinga Newsdesk July 15, 9:21 AM Morgan Stanley analyst Richard Hill maintains American Homes 4 Rent (NYSE:AMH) with a Equal-Weight and lowers the price target from $39 to $37.5. AMH
Read More 1 minute read Analyst Ratings News Price Target Stifel Maintains Hold on Wayfair, Lowers Price Target to $55 By Benzinga Newsdesk July 15, 9:19 AM Stifel analyst Scott Devitt maintains Wayfair (NYSE:W) with a Hold and lowers the price target from $60 to $55. W
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on ACADIA Pharmaceuticals, Lowers Price Target to $22 By Benzinga Newsdesk July 15, 9:13 AM Morgan Stanley analyst Jeffrey Hung maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Equal-Weight and lowers the price target from $24 to $22. ACAD
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Underweight on Abiomed, Lowers Price Target to $235 By Benzinga Newsdesk July 15, 9:09 AM Morgan Stanley analyst David Lewis maintains Abiomed (NASDAQ:ABMD) with a Underweight and lowers the price target from $275 to $235. ABMD
Read More 1 minute read Analyst Ratings News Price Target Stifel Maintains Hold on Canadian National Railway, Lowers Price Target to $113 By Benzinga Newsdesk July 15, 9:05 AM Stifel analyst Benjamin Nolan maintains Canadian National Railway (NYSE:CNI) with a Hold and lowers the price target from $124 to $113. CNI
Read More 1 minute read Analyst Ratings News Price Target Stifel Maintains Hold on Canadian Pacific Railway, Raises Price Target to $79 By Benzinga Newsdesk July 15, 9:03 AM Stifel analyst Benjamin Nolan maintains Canadian Pacific Railway (NYSE:CP) with a Hold and raises the price target from $78 to $79. CP
Read More 1 minute read Analyst Ratings News Price Target Deutsche Bank Maintains Hold on Conagra Brands, Lowers Price Target to $32 By Benzinga Newsdesk July 15, 8:57 AM Deutsche Bank analyst Steve Powers maintains Conagra Brands (NYSE:CAG) with a Hold and lowers the price target from $35 to $32. CAG